Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 13/20 | 0.56 |
| ▸ | CA1 | P00915 | 10/20 | 0.56 |
| ▸ | CA9 | Q16790 | 9/20 | 0.56 |
| ▸ | CA12 | O43570 | 6/20 | 0.56 |
| ▸ | CA6 | P23280 | 4/20 | 0.56 |
| ▸ | CA4 | P22748 | 3/20 | 0.56 |
| ▸ | CA5A | P35218 | 3/20 | 0.56 |
| ▸ | CA7 | P43166 | 3/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | PTGES2 | Q9H7Z7 | 4/20 | 0.53 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | LDHA | P00338 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL307454 | 1.00 | CA2 (0.56) | CA2CA1CA9CA12CA6 | |
| Hydrochloric Acid SCHEMBL7460198 | 0.98 | CA2 (0.54) | CA2CA1CA9CA12CA6 | |
| Hydrochloric Acid SCHEMBL21326134 | 0.98 | CA2 (0.54) | CA2CA1CA9CA12CA6 | |
| Formic Acid SCHEMBL6027486 | 0.89 | CA1 (0.47) | CA2CA1CA9CA12CA6 | |
| SCHEMBL2568298 | 0.82 | ALOX5AP (0.49) | CA2CA1CA9CA12CA6 | |
| SCHEMBL2051439 | 0.82 | NFE2L2 (0.43) | — | |
| SCHEMBL789494 | 0.81 | PTGES2 (0.64) | CA2CA1CA9CA12CA6 | |
| SCHEMBL30307782 | 0.81 | PTGES2 (0.64) | CA2CA1CA9CA12CA6 | |
| SCHEMBL202947 | 0.81 | CA2 (0.70) | CA2CA1CA9CA12CA6 | |
| Hydrochloric Acid SCHEMBL9955460 | 0.79 | PTGES2 (0.62) | CA2CA1CA9CA12CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250145589-A1 | PYRIDINE DERIVATIVE AND USE THEREOF | SICHUAN HUIYU PHARMACEUTICAL CO., LTD. (CN) | 2025-05-08 | — | — | US | disclosed |
| WO-2025006659-A1 | MIXTURES OF BIXLOZONE WITH PHOTOSYSTEM I ELECTRON DIVERTERS | FMC CORPORATION (US) | 2025-01-02 | — | — | WO | disclosed |
| CN-117945962-A | Synthesis method of bicalutamide | 中国人民大学 | 2024-04-30 | — | — | CN | disclosed |
| WO-2023028077-A1 | SODIUM CHANNEL INHIBITORS AND METHODS OF DESIGNING SAME | GENENTECH, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| EP-4077289-A1 | 2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE | Oxford Drug Design Limited (GB) | 2022-10-26 | — | — | EP | disclosed |
| CN-109153649-B | Allosteric modulators of nicotinic acetylcholine receptors | 默沙东公司 | 2022-04-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145589-A1 | PYRIDINE DERIVATIVE AND USE THEREOF | KRAS, NRAS, BRAF | CA2 3676/4885CA1 3768/4885CA9 2805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.